Inhibition of O-GlcNAc transferase activates cGAS-STING pathway
Data files
Sep 30, 2024 version files 8.49 MB
-
Figure_1—source_data_1_Uncropped_and_labelled_gels_for_Figure_1.zip
418.26 KB
-
Figure_1—source_data_2_Raw_unedited_gels_for_Figure_1.zip
328.85 KB
-
Figure_2-_figure_supplement_1—source_data_1._Uncropped_and_labelled_gels_for_Supplemental_Figure_2.zip
259.01 KB
-
Figure_2-_figure_supplement_1—source_data_2._Raw_unedited_gels_for_Supplemental_Figure_2.zip
232.32 KB
-
Figure_2—source_data_1_Uncropped_and_labelled_gels_for_Figure_2.zip
88.59 KB
-
Figure_2—source_data_2_Raw_unedited_gels_for_Figure_2.zip
41.97 KB
-
Figure_3—source_data_1_Uncropped_and_labelled_gels_for_Figure_3.zip
2.75 MB
-
Figure_3—source_data_2_Raw_unedited_gels_for_Figure_3.zip
1.58 MB
-
Figure_4—source_data_1_Uncropped_and_labelled_gels_for_Figure_4.zip
483.37 KB
-
Figure_4—source_data_2_Raw_unedited_gels_for_Figure_4.zip
212.62 KB
-
Figure_5-figure_supplement_1—source_data_1._Uncropped_and_labelled_gels_Supplemental_Figure_5A-B.zip
180.03 KB
-
Figure_5-figure_supplement_1—source_data_2._Raw_unedited_gels_for_Supplemental_Figure_5A-B.zip
105.80 KB
-
Figure_5—source_data_1_Uncropped_and_labelled_gels_for_Figure_5.zip
633.95 KB
-
Figure_5—source_data_2_Raw_unedited_gels_for_Figure_5.zip
387.26 KB
-
Figure_7—source_data_1_Uncropped_and_labelled_gels_for_Figure_7.zip
457.58 KB
-
Figure_7—source_data_2_Raw_unedited_gels_for_Figure_7.zip
334.68 KB
-
README.md
4.34 KB
Abstract
The O-GlcNAc transferase (OGT) is an essential enzyme that mediates protein O-GlcNAcylation, a unique form of posttranslational modification of many nuclear and cytosolic proteins. Recent studies observed increased OGT and O-GlcNAcylation levels in a broad range of human cancer tissues compared to adjacent normal tissues, indicating a universal effect of OGT in promoting tumorigenesis. Here, we show that OGT is essential for tumor growth in immunocompetent mice by repressing the cyclic GMP-AMP synthase (cGAS)-dependent DNA sensing pathway. We found that deletion of OGT (Ogt−/−) caused a marked reduction in tumor growth in both syngeneic mouse tumor models and a genetic mice colorectal cancer (CRC) model induced by mutation of the Apc gene (Apcmin). Pharmacological inhibition or genetic deletion of OGT induced robust genomic instability (GIN), leading to cGAS-dependent production of the type I interferon (IFN-I) and IFN-stimulated genes (ISGs). As a result, deletion of Cgas or Sting from Ogt−/− cancer cells restored tumor growth, and this correlated with impaired CD8+ T cell-mediated antitumor immunity. Mechanistically, we found that OGT-dependent cleavage of host cell factor C1 (HCF-1) is required for the avoidance of GIN and IFN-I production in tumors. In summary, our results identify OGT-mediated genomic stability and activate the cGAS-STING pathway as an important tumor cell-intrinsic mechanism to repress antitumor immunity.
README: Inhibition of O-GlcNAc transferase activates cGAS-STING pathway
https://doi.org/10.5061/dryad.4mw6m90ks
Description of the data and file structure
We have submitted our raw data from western blotting and agarose gel experiments.
Western blot data:
Figure 1—source data 1. Uncropped and labeled gels for Figure 1 (Figure 1G and Figure 1J)
Figure 1—source data 2. Raw unedited gels for Figure 1(Figure 1G and Figure 1J)
Figure 1G: Western blot analysis of OGT and O-GlcNAc expression in normal, adjacent, and tumor tissues in Apcmin spontaneous tumor mice.
Figure 1J: Western blot analysis of OGT and O-GlcNAc expression in normal, adjacent, and tumor tissues in the CAC model.
Figure 2—source data 1. Uncropped and labelled gels for Figure 2 (Figure 2A)
Figure 2—source data 2. Raw unedited gels for Figure 2 (Figure 2A)
Figure 2A: Western blot analysis of OGT expression in intestinal tissues and counting tumor numbers in APCmin and Ogt IEC cKO mice.
Figure 3—source data 1. Uncropped and labelled gels for Figure 3 (Figure 3E-3L)
Figure 3—source data 2. Raw unedited gels for Figure 3 (Figure 3E-3L)
Figure 3E: Western blot analysis of the activation of the interferon signaling pathway in different Ogt−/− cell lines including MC38, LLC, and B16-OVA cells.
Figure 3F: Western blot analysis of the activation of the interferon signaling pathway in Ogt−/− rescued cell lines including MC38, LLC, HT29, and B16-OVA cells.
Figure 3H: Western blot analysis of the activation of the interferon signaling pathway in different Ogt−/−Mavs−/− double knockout clones in MC38 cells.
Figure 3L: Western blot analysis of the activation of the interferon signaling pathway in Ogt−/−cGAS−/− or Ogt−/−Sting−/− double knockout clones in MC38, HT29, and B16-OVA cells.
Figure 4—source data 1. Uncropped and labelled gels for Figure 4 (Figure 4C-4F)
Figure 4—source data 2. Raw unedited gels for Figure 4 (Figure 4C-4F)
Figure 4C: Western blot analysis of γH2AX and H2AX expression in different* Ogt*−/− cell lines including MC38, LLC, and B16-OVA cells.
Figure 4F: Western blot analysis of γH2AX and H2AX expression in Ogt−/− rescued cells including MC38, LLC, HT29, and B16-OVA cells.
Figure 5—source data 1. Uncropped and labelled gels for Figure 5 (Figure 5B-5G)
Figure 5—source data 2. Raw unedited gels for Figure 5 (Figure 5B-5G)
Figure 5B: OGT and HCF1 binding was confirmed by immunoprecipitation assay in OGT-rescued HT29 cells.
Figure 5C: OGT and HCF1 binding was confirmed by immunoprecipitation assay in 293T cells.
Figure 5D: HCF1 cleavage was confirmed by western blot in Ogt rescued MC38 cells.
Figure 5E: Co-IP analysis of the interaction between OGT and different HCF-1 mutant
Figure 5G: Western blot analysis of γH2AX and H2AX expression in exogenous HCF-1C600 expressed MC38 Ogt knockout cells.
Figure 7—source data 1. Uncropped and labelled gels for Figure 7 (Figure 7B-7C)
Figure 7—source data 2. Raw unedited gels for Figure 7 (Figure 7B-7C)
Figure 7B: Western blot analysis of protein expression in MC38 treated with 50 μM and 100 μM OSMI.
Figure 7C: Western blot analysis of protein expression in LLC cells treated with 50 μM and 100 μM OSMI.
Figure 5- Figure Supplement 1—source data 1. Uncropped and labelled gels Supplemental Figure 5A-B
Figure 5- Figure Supplement 1—source data 2. Raw unedited gels for Supplemental Figure 5A-B
A) His pull-down assays were used to analyze the interaction between HCF-1C600 and OGT. B) His-tagged OGT and HCF1 were expressed and purified, followed by SDS-PAGE separation and staining with Coomassie blue.
Agarose gel data:
Figure 2- Figure Supplement 1—source data 1. Uncropped and labelled gels for Supplemental Figure 2
Figure 2- Figure Supplement 1—source data 2. Raw unedited gels for Supplemental Figure 2
Genomic DNA was extracted from the tails of APCmin, Villin-Cre, and Ogtfl/fl mice and used for PCR with various primers. The resulting products were separated by agarose gel electrophoresis to determine the genotype.
Files and variables
Western blotting and agarose gel pictures, JPG files.
Code/software
NA
Access information
NA
Methods
The protein content in the supernatant was analyzed by western blot. For the western blot, electrophoresis of proteins was performed by using the NuPAGE system (Invitrogen) according to the manufacturer’s protocol. Briefly, cultured cells were collected and lysed with RIPA buffer. Proteins were separated on a NuPAGE gel and were transferred onto nitrocellulose membranes (Bio-Rad). Appropriate primary antibodies and HRP-conjugated secondary antibodies were used and proteins were detected using the Enhanced Chemiluminescent (ECL) reagent (Thermo Scientific). The images were acquired with the ChemiDoc MP System (Bio-Rad).